Investing in initial public offerings (IPOs) can be a lucrative opportunity for investors, and the Valiant Laboratories IPO is one that has caught the attention of many. With a strong reputation in the pharmaceutical industry, Valiant Laboratories is set to go public, and here’s all you need to know about its IPO pipeline.
IPO Timeline
The Valiant Laboratories IPO follows a well-defined pipeline, starting from the opening date and culminating in its listing on two major stock exchanges in India, NSE (National Stock Exchange) and BSE (Bombay Stock Exchange).
| Stage | Date | Details |
|---|---|---|
| Opening Date | 27th Sep 2023 | The IPO opens for subscription. |
| Closing Date | 03rd Oct 2023 | The IPO subscription period ends. |
| Allotment Date | 06th Oct 2023 | The process of allotting shares to investors begins. |
| Refund Date | 09th Oct 2023 | Excess money is refunded to investors if necessary. |
| Share Credit | 10th Oct 2023 | Shares allotted to investors are credited to their demat accounts. |
| Listing Date | 11th Oct 2023 | Valiant Laboratories’ shares are listed on NSE and BSE. Trading begins. |
About Valiant Laboratories
Valiant Laboratories, with a face value of ₹10 per share, is a distinguished name in the pharmaceutical sector. It boasts a rich history of producing high-quality pharmaceutical products and has successfully expanded its presence both nationally and internationally. Investors looking for a company with a solid track record and growth potential often find Valiant Laboratories appealing.
Retail Investors: A Significant Slice
One noteworthy aspect of the Valiant Laboratories IPO is the allocation for retail investors. A substantial 35% of the total shares are reserved for retail investors, underlining the company’s commitment to providing a fair chance to individual investors.
